≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Ankylosing spondylitis, strict definition

DOID EFO Endpoint Browser PheWeb

M13_ANKYLOSPON_STRICT

ankylosing spondylitis: An autoimmune chronic inflammatory disorder characterized by inflammation in the vertebral joints of the spine and sacroiliac joints. It predominantly affects young males. Patients present with stiffness and pain in the spine.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • M13_ANKYLOSPON_ICD10
3729

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • KELA reimbursements: KELA codes — ANY
  • KELA reimbursements: ICD-10 — M45

1 out of 7 registries used, show all original rules.

1773

4. Check minimum number of events

None

1773

5. Include endpoints

None

1773

6. Filter based on genotype QC (FinnGen only)

1773

Control definitions (FinnGen only)

Control conditions
not M13_ANKYLOSPON_ICD10

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF3

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8672 3328 5319
Only index persons 8532 3302 5230
Unadjusted period prevalence (%)
Whole population 0.13 0.10 0.15
Only index persons 0.17 0.12 0.20
Median age at first event (years)
Whole population 37.75 38.28 37.43
Only index persons 37.70 38.29 37.33

-FinnGen-

Key figures

All Female Male
Number of individuals 1773 822 951
Unadjusted period prevalence (%) 0.35 0.28 0.42
Median age at first event (years) 39.13 38.10 40.02

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1586
Matched controls
15858
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
158.2
323.0
921
138
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
20.0
323.0
611
482
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
28.6
323.0
888
676
L04AB01
ATC
etanercept; parenteral
109.9
323.0
439
55
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
32.7
323.0
549
252
M45
ICD-10 Finland
Ankylosing spondylitis
+∞
323.0
1586
24
A07EC01
ATC
sulfasalazine; oral, rectal
342.1
323.0
1461
524
L04AB04
ATC
adalimumab; parenteral
84.2
323.0
552
100
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
159.5
323.0
949
146
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
7133.0
323.0
1582
714
L04AB06
ATC
golimumab; parenteral
116.0
296.3
316
34
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
69.4
289.9
331
60
L88
ICPC
Rheumatoid/seropositive arthritis
25.3
260.6
376
192
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
14.6
260.2
470
444
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
24.0
257.9
379
205
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
39.6
254.4
324
102
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
75.6
253.5
286
46
H02AB06
ATC
prednisolone; systemic
5.0
194.6
1089
4800
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
26.0
144.7
205
90
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
1366.6
131.2
126
*
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
13.8
128.6
231
194
M01AH01
ATC
celecoxib; oral (coxibs)
4.8
127.0
503
1389
M01AC06
ATC
meloxicam; systemic, rectal
3.7
126.6
822
3567
L04AC10
ATC
secukinumab; parenteral
90.7
120.3
133
16
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.1
120.2
601
2062
M01AH05
ATC
etoricoxib; oral
3.7
118.2
1216
7426
H20.1
ICD-10 Finland
Chronic iridocyclitis
39.2
112.4
143
40
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
390.3
110.8
110
*
L04AA13
ATC
leflunomide; oral
16.8
106.8
175
116
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
35.3
106.8
139
43
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
5.6
104.4
343
750
WZA10
NOMESCO Finland
Long statement of health and health related matters
23.4
98.2
143
67
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
94.6
789
3845
L04AA11
ATC
[U] etanercept; parenteral
68.0
94.0
108
17
S01FA04
ATC
cyclopentolate; ophthalmic
27.6
90.3
125
49
L04AB05
ATC
certolizumab pegol; parenteral
76.8
89.5
101
14
P01BA02
ATC
hydroxychloroquine; oral
5.8
84.3
261
522
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
12.7
84.2
155
134
S01FA02
ATC
scopolamine; ophthalmic
29.6
73.8
100
36
H02AB07
ATC
prednisone; oral
3.8
68.8
333
1035
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
41.1
65.4
82
21
N02AX02
ATC
tramadol; systemic, rectal
2.5
65.2
752
4151
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
10.8
54.6
108
107
M01AH02
ATC
rofecoxib; oral
3.9
54.1
250
735
A02BC02
ATC
pantoprazole; systemic
2.3
53.9
1041
7176
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
6.3
53.0
149
258
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
16.9
50.9
82
51
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.0
50.0
218
606
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
503.1
49.7
49
*
M13.9
ICD-10 Finland
Arthritis, unspecified
4.2
48.2
199
526
ZX120
NOMESCO Finland
Intravenous
3.9
47.8
214
608
M01AE02
ATC
naproxen; oral, rectal
2.1
45.6
981
6831
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.3
45.2
589
3281
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
8.0
44.8
105
140
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
14.8
44.3
75
53
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
44.3
821
5337
L04AA17
ATC
[U] adalimumab; parenteral
49.8
44.1
53
11
M01AX17
ATC
nimesulide; oral
2.5
42.1
395
1853
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
34.2
40.9
53
16
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
9.5
40.5
85
94
M01AX01
ATC
nabumetone; oral
5.7
39.6
118
219
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.3
38.8
124
250
R4110
NOMESCO Finland
Physiotherapy
2.3
38.5
460
2421
UJF32
NOMESCO Finland
Coloscopy
2.4
37.3
392
1930
M46.8
ICD-10 Finland
Other specified inflammatory spondylopathies
37.2
37.0
47
13
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
5.8
36.9
108
196
M05BA04
ATC
alendronic acid; oral
5.1
36.3
120
251
M03BX02
ATC
tizanidine; oral
2.0
36.3
1088
8267
M01CB01
ATC
sodium aurothiomalate; parenteral
14.4
35.8
61
44
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.9
35.6
243
936
TNG10
NOMESCO Finland
Puncture of knee
14.9
35.2
59
41
A02BC03
ATC
lansoprazole; oral
2.2
35.2
457
2482
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
8.8
34.4
75
89
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
33.5
289
1276
NF1AA
NOMESCO Finland
Hip X-ray examination
4.0
33.0
141
381
M01AB05
ATC
diclofenac; systemic, rectal
2.0
32.6
1117
8717
M01AE03
ATC
ketoprofen; systemic, rectal
2.0
31.6
596
3737
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
31.3
168
547
XX9XE
NOMESCO Finland
Other ultrasound examination
12.3
30.3
55
46
L04AX01
ATC
azathioprine; systemic
3.9
29.7
128
348
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
29.6
665
4407
M54.5
ICD-10 Finland
Low back pain
1.9
29.2
564
3541
H04.10
ICD-10 Finland
Dry eye syndrome
3.0
29.0
184
672
M01AB01
ATC
indometacin; systemic, rectal
3.5
28.8
140
421
N02BE01
ATC
paracetamol; systemic, rectal
2.1
28.3
1311
11077
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.5
28.1
139
424
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
13.3
27.5
48
37
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
27.1
634
4223
UJF30
NOMESCO Finland
Ileoscopy through colon
2.8
27.0
192
752
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
6.2
27.0
74
124
L04AA01
ATC
[U] ciclosporin; systemic
7.9
26.4
61
80
ZX140
NOMESCO Finland
Intra articular
11.2
25.9
49
45
H22.1
ICD-10 Finland
Iridocyclitis in other diseases classified elsewhere
95.0
25.7
28
*
M01AB55
ATC
diclofenac, combinations; oral
3.5
25.2
121
361
4AB02
NOMESCO Finland
NA
15.3
23.8
39
26
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.2
23.6
129
424
NH3EA
NOMESCO Finland
Feet X-ray examination with load
6.5
23.5
62
99
M03BC01
ATC
orphenadrine (citrate); systemic
1.9
23.4
437
2663
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
23.4
394
2311
M46.0
ICD-10 Finland
Spinal enthesopathy
54.9
23.1
27
5
RK220
NOMESCO Finland
NA
27.8
22.3
30
11
S01BC03
ATC
diclofenac; ophthalmic
5.8
22.2
64
115
3640A
ICD-9 Finland
Disorders of iris and ciliary body, Acute and subacute iridocyclitis
52.8
22.1
26
5
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.6
21.6
100
290
M25.5
ICD-10 Finland
Pain in joint
1.8
21.4
459
2917
H15.1
ICD-10 Finland
Episcleritis
6.5
21.1
55
87
NG1DA
NOMESCO Finland
X-ray of knees
6.9
20.9
52
77
K50.8
ICD-10 Finland
Other Crohn disease
5.3
20.7
64
125
A07EC02
ATC
mesalazine; oral, rectal
2.9
20.5
131
477
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
13.2
20.2
35
27
H02AB04
ATC
methylprednisolone; systemic
2.1
20.1
237
1199
4AA12
NOMESCO Finland
NA
17.5
20.0
31
18
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.6
19.9
154
633
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.7
19.7
142
559
K50.0
ICD-10 Finland
Crohn disease of small intestine
5.4
19.2
58
111
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
5.7
19.1
55
99
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
5.0
19.0
61
125
A02BC05
ATC
esomeprazole; systemic
1.7
18.8
587
4138
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
9.5
18.7
38
41
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.4
18.5
166
738
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
5.3
18.4
56
108
J01DB01
ATC
cefalexin; oral
1.8
18.4
1277
11134
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.1
18.3
58
117
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
5.0
18.2
59
122
K02.1
ICD-10 Finland
Caries of dentine
1.6
17.8
941
7577
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.1
17.8
69
172
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
8.4
17.5
38
46
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.9
17.3
108
387
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
17.2
560
3971
A07EA06
ATC
budesonide; oral, local oral
3.5
17.0
82
246
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
17.0
99
341
H57.1
ICD-10 Finland
Ocular pain
3.6
16.9
77
221
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
16.8
1032
8562
M01AC01
ATC
piroxicam; systemic, rectal
2.1
16.6
195
982
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
27.9
16.5
22
8
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
16.4
471
3216
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
6.8
16.4
41
62
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
12.3
16.4
29
24
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
7.2
16.3
39
55
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.5
16.2
134
568
RK210
NOMESCO Finland
NA
30.4
16.1
21
7
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
8.0
16.1
36
46
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
5.2
15.8
49
97
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
4.3
15.7
58
138
H20
ICD-10 Finland
Iridocyclitis
13.1
15.7
27
21
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.3
15.6
152
702
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
15.6
834
6636
S01FA06
ATC
tropicamide; ophthalmic
85.9
15.6
17
*
M03BC51
ATC
orphenadrine, combinations; systemic
1.6
15.6
452
3089
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.7
15.3
383
2508
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
9.3
15.2
31
34
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.4
15.1
75
231
N03AX12
ATC
gabapentin; oral
2.0
15.0
212
1149
36400
ICD-8 Finland
Iritis, Iridocyclitis acuta
32.0
14.8
19
6
M01AB08
ATC
etodolac; oral
2.4
14.6
127
553
J01CA04
ATC
amoxicillin; systemic
1.6
14.6
1246
10988
WZC30
NOMESCO Finland
Teaching
2.0
14.6
195
1035
M07.2*L40.5
ICD-10 Finland
Psoriatic spondylitis
36.4
14.4
18
5
RF420
NOMESCO Finland
NA
6.4
14.3
37
59
M54.6
ICD-10 Finland
Pain in thoracic spine
2.4
14.2
125
549
L02
ICPC
Back symptom/complaint
2.2
14.1
147
700
L04AD01
ATC
ciclosporin; systemic
4.5
14.1
50
115
M01CB03
ATC
auranofin; oral
12.8
13.9
24
19
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
13.8
924
7635
M54.8
ICD-10 Finland
Other dorsalgia
3.1
13.6
75
250
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
13.4
1108
9562
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
7.8
13.4
30
39
RF120
NOMESCO Finland
NA
7.1
13.4
32
46
N03AX16
ATC
pregabalin; oral
1.7
13.3
315
2021
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
13.3
529
3883
SPAT1325
SPAT
Vaccination
1.6
13.3
386
2622
K51.5
ICD-10 Finland
Left sided colitis
3.2
13.2
70
227
NF1DA
NOMESCO Finland
X-ray of hips
5.4
13.2
39
74
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
13.2
178
945
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.3
13.1
67
212
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
15.2
13.1
21
14
N06AA09
ATC
amitriptyline; systemic
2.2
13.1
133
627
K50.9
ICD-10 Finland
Crohn disease, unspecified
4.4
13.1
47
110
L99
ICPC
Musculoskeletal disease other
4.7
12.9
43
93
H02AB08
ATC
triamcinolone; systemic
19.2
12.9
19
10
L34
ICPC
Musculoskeletal, Blood test
50.4
12.9
15
*
L84
ICPC
Back syndrome without radiat pain
2.8
12.8
81
296
M01AE52
ATC
naproxen and esomeprazole; oral
3.2
12.8
66
210
F01
ICPC
Eye pain
3.8
12.8
53
142
RF410
NOMESCO Finland
NA
6.1
12.7
34
57
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
5.8
12.7
35
61
M35.7
ICD-10 Finland
Hypermobility syndrome
4.9
12.7
41
86
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.6
12.6
93
371
J01MA02
ATC
ciprofloxacin; systemic
1.5
12.2
501
3689
A02BC01
ATC
omeprazole; systemic
1.6
12.1
335
2238
WZA90
NOMESCO Finland
Other doctors statement
1.6
11.9
327
2179
M01AH03
ATC
valdecoxib; oral
2.5
11.8
91
373
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.2
11.7
35
68
M13.8
ICD-10 Finland
Other specified arthritis
6.1
11.7
31
52
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
5.8
11.7
32
56
Z50.1
ICD-10 Finland
Other physical therapy
2.6
11.6
84
332
S01FA01
ATC
atropine; ophthalmic
12.6
11.6
20
16
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.4
11.4
833
6882
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.5
11.3
51
148
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
11.2
389
2746
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
11.2
449
3278
NA6BM
NOMESCO Finland
Sacro-iliac joint MRI examination with 3 Tesla magnet
25.2
11.1
15
6
TNF11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in hip joint
25.2
11.1
15
6
M02AA07
ATC
piroxicam; topical
1.5
11.1
442
3216
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.9
11.1
44
114
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
10.9
265
1708
N06AX21
ATC
duloxetine; oral
1.9
10.7
165
922
NAJ12
NOMESCO Finland
Posterior reduction of fracture of cervical spine
60.4
10.6
12
*
RT171
NOMESCO Finland
NA
110.7
10.4
11
*
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
110.7
10.4
11
*
M08.1
ICD-10 Finland
Juvenile ankylosing spondylitis
110.7
10.4
11
*
J01AA02
ATC
doxycycline; systemic
1.5
10.4
1123
9916
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
10.3
578
4507
K50.1
ICD-10 Finland
Crohn disease of large intestine
4.2
10.3
38
93
R2110
NOMESCO Finland
Giving the first information
2.1
10.2
111
541
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.3
10.2
30
58
M47.82
ICD-10 Finland
Other spondylosis, cervical region
3.0
10.1
58
199
A02BB01
ATC
misoprostol; oral
11.4
10.1
18
16
M79.7
ICD-10 Finland
Fibromyalgia
2.9
10.0
58
202
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
3.5
9.9
45
132
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.7
9.8
41
112
R06.0
ICD-10 Finland
Dyspnoea
1.6
9.7
269
1789
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
9.6
245
1597
K51.8
ICD-10 Finland
Other ulcerative colitis
4.4
9.5
33
76
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
9.1
9.5
19
21
UJF92
NOMESCO Finland
Capsular endoscopy
3.4
9.5
44
131
71490
ICD-8 Finland
Other specified forms of arthritis, Arthritis postinfectiosa NUD
30.2
9.4
12
*
S01ED01
ATC
timolol; ophthalmic
3.5
9.4
42
122
Z01.2
ICD-10 Finland
Dental examination
1.4
9.3
594
4722
L03
ICPC
Low back symptom/complaint
1.5
9.3
311
2167
R42
ICD-10 Finland
Dizziness and giddiness
1.7
9.1
219
1402
7168A
ICD-9 Finland
Other and unspecified arthropathies, Other specified arthropathy
36.9
9.0
11
*
SPAT1263
SPAT
Sampling
1.4
8.9
554
4374
M16.7
ICD-10 Finland
Other secondary coxarthrosis
6.4
8.8
22
35
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
8.7
1428
13419
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
8.7
588
4710
K07.60
ICD-10 Finland
Snapping jaw
2.2
8.7
83
382
M70.6
ICD-10 Finland
Trochanteric bursitis
1.9
8.7
120
642
3029
Kela drug reimbursment
Upadacitinib
50.3
8.7
10
*
P01AB01
ATC
metronidazole; oral, rectal
1.4
8.7
521
4083
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
8.6
104
530
RK250
NOMESCO Finland
NA
7.7
8.6
19
25
H26.3
ICD-10 Finland
Drug-induced cataract
7.7
8.6
19
25
RT272
NOMESCO Finland
NA
11.6
8.6
15
13
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
8.6
94
460
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
7.0
8.5
20
29
RF210
NOMESCO Finland
NA
2.9
8.5
49
170
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
8.5
107
555
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
8.5
621
5034
RT271
NOMESCO Finland
NA
27.7
8.5
11
*
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
7.4
8.4
19
26
7202A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Sacro-iliitis, not elsewhere classified
90.5
8.4
9
*
S01FB01
ATC
phenylephrine; ophthalmic (sympathomimetics excl. antiglaucoma prep.)
90.5
8.4
9
*
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.6
8.4
36
102
C10AC01
ATC
colestyramine; oral
3.2
8.3
42
135
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
4.0
8.3
31
78
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.5
8.2
37
109
D07AC01
ATC
betamethasone; topical
1.4
8.2
435
3323
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
8.2
174
1078
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
7.6
8.2
18
24
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
8.1
820
6993
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
33.5
8.1
10
*
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
4.5
8.1
27
61
A02BA02
ATC
ranitidine; systemic
1.6
8.0
208
1355
S01ED51
ATC
timolol, combinations; ophthalmic
2.5
8.0
62
257
H30.2
ICD-10 Finland
Posterior cyclitis
10.1
8.0
15
15
D06BB04
ATC
podophyllotoxin; topical
1.9
8.0
111
598
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
7.9
309
2222
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
7.9
67
291
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.7
7.9
160
975
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
3.5
7.9
35
102
M13.0
ICD-10 Finland
Polyarthritis, unspecified
4.1
7.9
29
72
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.8
255
1758
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
7.8
277
1948
SPAT1153
SPAT
Removal of sutures
1.5
7.8
353
2614
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.3
7.8
70
315
RS221
NOMESCO Finland
NA
3.8
7.8
31
83
A07EA02
ATC
hydrocortisone; rectal
3.0
7.7
42
143
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
7.7
309
2234
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
5.6
7.7
21
38
R35
ICD-10 Finland
Polyuria
2.3
7.6
68
304
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.6
223
1502
Z71.8
ICD-10 Finland
Other specified counselling
1.5
7.6
313
2273
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
18.4
7.6
11
6
M02AA10
ATC
ketoprofen; topical
1.6
7.6
193
1251
R50.9
ICD-10 Finland
Fever, unspecified
1.7
7.6
176
1114
M07.3
ICD-10 Finland
Other psoriatic arthropathies
4.5
7.6
25
56
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
6.2
7.5
19
31
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
7.5
83
410
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
5.8
7.5
20
35
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.0
7.5
41
140
-44
ICPC
Preventive immunization/medic
2.0
7.5
87
439
M05BB03
ATC
alendronic acid and colecalciferol; oral
4.4
7.5
25
57
M01AA01
ATC
phenylbutazone; systemic, rectal
80.5
7.4
8
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.0
7.4
90
461
ZX112
NOMESCO Finland
Subcutaneous
3.5
7.4
32
92
N02AC04
ATC
dextropropoxyphene; oral
3.2
7.4
37
119
M02.1
ICD-10 Finland
Postdysenteric arthropathy
8.4
7.3
15
18
J99.8*M45
ICD-10 Finland
Respiratory disorders in ankylosing spondylitis
+∞
7.3
7
*
NA6DG
NOMESCO Finland
Sacro-iliac joint very extensive MRI examination with high intensity magnet
+∞
7.3
7
*
R51.80
ICD-10 Finland
Headache
1.6
7.3
203
1349
M02.8
ICD-10 Finland
Other reactive arthropathies
6.3
7.2
18
29
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
7.1
294
2132
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
7.1
217
1473
ZX114
NOMESCO Finland
Intramuscular
3.6
7.1
30
85
WX290
NOMESCO Finland
Other blockade of nerve
1.3
7.1
716
6060
NA3BM
NOMESCO Finland
Lumbar spine MRI examination with 3 Tesla magnet
8.8
7.0
14
16
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
7.0
468
3708
N20.9
ICD-10 Finland
Urinary calculus, unspecified
2.9
7.0
41
146
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
7.0
738
6282
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.9
7.0
40
139
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
6.9
224
1541
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
6.4
6.9
17
27
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
13.8
6.9
11
8
M17.5
ICD-10 Finland
Other secondary gonarthrosis
5.0
6.8
20
40
L04AC13
ATC
ixekizumab; parenteral
11.0
6.8
12
11
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
4.0
6.8
25
63
M05BA06
ATC
ibandronic acid; systemic
5.3
6.8
19
36
SPAT1202
SPAT
Intra-articular injection
3.1
6.8
35
116
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
6.7
163
1047
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.5
6.7
51
212
L01CB
ATC
Podophyllotoxin derivatives
22.6
6.7
9
*
M54.2
ICD-10 Finland
Cervicalgia
1.9
6.6
98
539
L04AC05
ATC
ustekinumab; parenteral
6.5
6.6
16
25
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.3
6.6
56
245
R5120
NOMESCO Finland
Preparation of an aid
3.5
6.6
29
85
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
6.6
216
1489
NA3BA
NOMESCO Finland
Lumbar spine extensive X-ray examination without contrast
12.3
6.6
11
9
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
12.3
6.6
11
9
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
6.6
707
6014
M25.4
ICD-10 Finland
Effusion of joint
4.4
6.5
22
51
B01AB05
ATC
enoxaparin; parenteral
1.4
6.5
316
2361
J01FA10
ATC
azithromycin; systemic
1.3
6.5
850
7426
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
6.5
129
784
L28
ICPC
Limited function/disability (L)
1.7
6.4
135
834
VALMI
NOMESCO Finland
NA
1.4
6.4
341
2591
R03AC02
ATC
salbutamol; inhalant
1.3
6.4
715
6108
L40.5
ICD-10 Finland
Arthropathic psoriasis
3.1
6.4
32
104
-1
NOMESCO Finland
NA
1.3
6.4
479
3857
H26.2
ICD-10 Finland
Complicated cataract
3.8
6.4
25
67
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
6.4
557
4588
N20.0
ICD-10 Finland
Calculus of kidney
3.1
6.3
32
105
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.6
6.3
151
967
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
9.3
6.3
12
13
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
4.6
6.3
20
44
M03.2
ICD-10 Finland
Other postinfectious arthropathies in diseases classified elsewhere
+∞
6.3
6
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.8
6.2
111
650
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.9
6.2
91
500
NA6CF
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with median intensity magnet
26.8
6.2
8
*
TNE11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in sacroiliac joint
26.8
6.2
8
*
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
3.7
6.2
25
69
WX110
NOMESCO Finland
Local anesthesy
1.3
6.2
1014
9121
ZXA00
NOMESCO Finland
Right side
1.4
6.2
287
2129
N02AA05
ATC
oxycodone; systemic
1.7
6.2
129
796
S01EC01
ATC
acetazolamide; systemic
3.2
6.2
30
96
SPAT1251
SPAT
Organisation of medication
2.6
6.1
41
160
S01EE03
ATC
bimatoprost; ophthalmic
4.2
6.1
21
50
XCH00
NOMESCO Finland
Eye pressure measurement
2.7
6.1
40
153
R51.81
ICD-10 Finland
Facial pain NOS
2.9
6.1
33
114
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.5
6.1
44
180
KMAK
NOMESCO Finland
NA
1.3
6.0
800
6976
J01FF01
ATC
clindamycin; systemic
1.4
6.0
355
2744

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
205
56
41.26
307.65
1.6
2.4
mg/l
9.3
9.6
0.14
161
48
(3019198) Lymphocytes [#/volume] in Blood
1595
7251
12.95
307.65
12.7
6.1
e9/l
2.1
2.0
3.63
1548
6476
(3006315) Basophils [#/volume] in Blood
1587
7033
12.98
307.65
12.7
6.1
e9/l
0.0
0.0
3.14
1533
6162
(3013115) Eosinophils [#/volume] in Blood
1601
7292
13.32
307.65
12.9
6.4
e9/l
0.2
0.2
1.33
1554
6498
(42870588) Differential panel, method unspecified - Blood
1234
4525
6.68
307.65
11.1
6.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
441
481
11.87
307.65
1.6
1.6
iu/ml
0.9
0.3
0.55
114
85
(3001604) Monocytes [#/volume] in Blood
1584
7016
12.80
307.65
12.6
6.1
e9/l
0.6
0.6
4.93
1528
6154
(3013650) Neutrophils [#/volume] in Blood by Automated count
1623
8016
13.11
301.79
15.0
9.5
e9/l
3.8
4.1
8.50
1568
7036
(3022096) Basophils/100 leukocytes in Blood
1439
6362
7.70
300.25
13.2
6.3
%
0.7
0.7
4.25
1410
5984
(3006504) Eosinophils/100 leukocytes in Blood
1458
6576
7.85
295.71
13.0
6.2
%
2.7
2.9
2.53
1429
6174
(3019069) Monocytes/100 leukocytes in Blood
1463
6620
7.92
295.62
13.4
6.4
%
8.8
8.5
5.26
1432
6256
(3018010) Neutrophils/100 leukocytes in Blood
1465
6757
7.72
285.72
12.6
6.0
%
54.1
56.6
17.12
1432
6382
(3002030) Lymphocytes/100 leukocytes in Blood
1468
6849
7.65
280.42
13.2
6.2
%
31.9
28.9
27.25
1437
6450
(3013707) Erythrocyte sedimentation rate by Westergren method
1689
10199
14.85
210.69
10.6
3.7
mm/h
10.6
9.4
3.83
1669
9584
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1663
10428
10.59
183.01
12.0
7.3
u/l
72.1
75.2
3.45
1640
9898
(3025159) Blasts/100 leukocytes in Blood
412
990
5.12
164.45
5.5
4.5
%
0.0
0.5
0.75
79
234
(3021440) Promyelocytes/100 leukocytes in Blood
425
1054
4.99
163.25
5.5
4.4
%
0.1
0.1
1.74
86
281
(3017181) Myelocytes/100 leukocytes in Blood
436
1111
4.88
161.93
5.4
4.4
%
0.6
0.9
1.40
87
306
(40760892) CBC W Ordered Manual Differential panel - Blood
841
3496
3.67
156.65
7.5
4.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
408
1016
4.92
155.41
4.7
4.2
%
0.3
0.6
2.02
78
226
(3037467) Urinalysis macro (dipstick) panel - Urine
1502
9188
5.15
154.13
6.9
3.7
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
154
150
11.15
140.59
1.3
1.4
iu/ml
23.0
30.0
—
5
7
(3021601) Nitrite [Presence] in Urine by Test strip
1214
6675
3.60
139.27
6.3
4.2
estimate
0.0
0.0
0.50
293
1279
(3009261) Glucose [Presence] in Urine by Test strip
1217
6736
3.57
137.36
5.0
3.1
estimate
0.0
0.0
0.14
278
1202
(3035350) Ketones [Presence] in Urine by Test strip
1209
6674
3.55
136.84
4.9
3.0
estimate
0.0
0.0
0.80
268
1226
(3021589) Normoblasts [#/volume] in Blood
1158
6234
3.47
136.42
14.6
8.8
e9/l
0.0
0.0
0.94
1071
5143
(3037522) Nuclear Ab [Titer] in Serum
574
2085
3.59
127.42
1.4
1.4
titre
425.4
523.5
0.91
126
405
(3030905) Polymorphonuclear cells [#/volume] in Blood
183
279
7.20
116.45
3.6
3.7
e9/l
3.8
4.0
1.08
183
279
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
184
287
7.04
114.60
3.8
4.0
%
53.4
56.6
2.68
184
287
(3011397) Hemoglobin [Presence] in Urine by Test strip
679
2900
3.17
113.58
4.7
3.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
93
69
14.17
100.35
2.7
3.1
mg/l
6.8
8.1
0.74
77
60
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
88
62
14.88
97.73
2.5
2.4
au/ml
98.4
98.1
—
10
9
(40758558) Short blood count panel - Blood
720
3423
2.86
96.08
10.0
6.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
261
667
4.42
93.64
1.1
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
935
5334
2.59
83.49
2.6
2.3
nmol/l
74.2
73.6
0.32
893
4939
(3017143) Hepatitis C virus Ab [Presence] in Serum
503
2139
2.89
80.54
1.4
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
809
4422
2.53
77.46
3.7
3.4
e6/l
42.1
67.7
0.89
536
3064
(3000475) Leukocytes [#/volume] in Synovial fluid
148
281
5.66
75.09
2.1
1.6
e6/l
6807.6
11474.7
1.00
114
211
(3021879) Hepatitis B virus core Ab [Presence] in Serum
376
1412
3.11
74.73
1.3
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
124
203
6.49
73.22
2.0
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
155
316
5.28
72.66
1.7
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1744
14711
12.34
63.96
22.1
11.6
mg/l
14.6
21.8
27.26
1602
11352
(3029937) Albumin [Presence] in Urine by Test strip
653
3484
2.38
62.91
6.3
3.4
estimate
0.0
0.0
1.28
287
1236
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
547
2795
2.38
57.18
1.5
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
846
5304
2.14
52.47
5.5
3.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
98
190
5.40
48.37
1.8
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
407
1953
2.41
47.94
3.9
2.5
ug/g
167.0
130.5
1.15
349
1579
(3019150) Specific gravity of Urine by Refractometry
527
2863
2.20
45.97
6.1
3.2
kg/l
1.0
1.0
0.65
66
367
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
523
2887
2.15
43.41
2.6
2.1
mg/l
2.9
2.8
0.81
462
2499
(3000850) Epithelial cells [#/volume] in Urine
466
2522
2.15
40.26
2.5
2.5
e6/l
3.2
5.5
5.04
424
2224
(40761535) Cells panel - Urine sediment
235
941
2.73
39.93
5.2
3.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1522
12643
2.44
38.25
22.5
14.0
%
13.6
13.5
3.18
1511
12381
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
72
131
5.69
38.02
2.1
1.5
%
41.6
56.5
1.93
46
85
(3017732) Neutrophils [#/volume] in Blood
237
989
2.61
36.97
3.6
2.6
e9/l
4.1
4.1
0.20
196
827
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1751
15860
9.38
35.57
22.2
9.2
u/l
28.8
29.7
1.37
1740
15476
(36304419) Bacteria [Presence] in Urine
558
3372
1.96
34.76
2.9
2.8
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
62
109
5.86
33.93
2.1
1.4
%
44.2
27.7
2.39
41
67
(3041096) Erythrocytes [Presence] in Urine by Automated
621
3920
1.90
33.72
4.3
2.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
555
3385
1.93
33.40
3.1
2.9
e6/l
0.2
0.4
3.03
445
2503
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1604
13876
2.64
32.87
15.4
10.2
ml/min/173m2
93.4
89.5
14.25
1442
11451
(3045414) Leukocytes [Presence] in Urine
156
556
2.98
32.74
1.6
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
307
1541
2.20
31.30
1.5
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
160
597
2.85
30.86
1.3
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
586
3728
1.85
30.39
3.1
3.0
e6/l
27.7
109.2
1.35
477
2831
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
373
2045
2.04
30.08
2.4
2.6
e6/l
0.7
0.9
0.88
249
1118
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
130
440
3.11
29.82
1.5
2.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
748
5235
1.74
27.40
5.1
6.4
mmol/l
1.2
1.2
1.59
704
4810
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
817
5865
1.73
27.28
5.2
7.0
mmol/l
1.2
1.2
1.46
698
4998
(3018418) pH of Serum or Plasma
538
3439
1.81
26.83
3.3
4.2
ph
7.4
7.4
0.58
103
660
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
111
368
3.15
26.34
1.2
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
228
1111
2.21
24.69
2.3
2.9
%
1.9
1.8
0.86
200
1004
(3022948) Iron [Moles/volume] in Serum or Plasma
333
1869
1.96
24.67
2.2
2.5
umol/l
13.3
14.4
2.11
316
1739
(3024561) Albumin [Mass/volume] in Serum or Plasma
731
5216
1.68
24.03
4.7
5.2
g/l
36.8
36.7
0.32
683
4912
(3028026) IgM [Mass/volume] in Serum or Plasma
191
895
2.27
22.68
1.5
1.9
g/l
1.2
1.3
0.63
183
839
(3034891) Synovial lining cells/100 cells in Synovial fluid
35
52
6.85
22.55
1.7
1.3
%
5.4
6.1
—
11
10
(3005719) IgG [Mass/volume] in Serum or Plasma
227
1143
2.13
22.54
2.0
2.6
g/l
11.1
10.5
1.60
210
1050
(3007566) Smooth muscle Ab [Titer] in Serum
116
444
2.73
21.24
1.3
1.3
titre
101.7
98.4
—
6
44
(3004809) Band form neutrophils/100 leukocytes in Blood
64
175
3.76
20.50
2.4
3.2
%
1.2
1.2
0.08
50
145
(3001122) Ferritin [Mass/volume] in Serum or Plasma
825
6256
1.60
20.11
3.2
2.7
ug/l
103.8
121.3
2.18
792
5901
(3045424) Erythrocytes [Presence] in Urine
77
241
3.29
20.10
1.3
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
454
2989
1.70
19.36
1.4
1.5
g/l
2.9
2.3
5.16
306
1999
(3010144) Erythrocytes [#/volume] in Synovial fluid
49
117
4.28
18.88
1.8
1.2
e6/l
10595.2
45549.3
0.74
37
85
(3031040) Bacteria [#/volume] in Urine by Automated count
1035
8358
1.57
18.66
4.3
3.6
e6/l
380.4
910.1
0.42
11
99
(46235355) HIV 1 and 2 tests - Meaningful Use set
516
3549
1.64
18.45
1.8
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
272
1596
1.83
17.12
2.3
2.6
%
22.9
24.6
1.15
243
1388
(3004789) Transferrin [Mass/volume] in Serum or Plasma
290
1737
1.80
17.06
2.2
2.5
g/l
2.4
2.4
0.13
273
1614
(3007461) Platelets [#/volume] in Blood
1762
16850
8.37
15.95
30.7
16.8
e9/l
271.7
253.3
25.76
1752
16518
(3023520) Reticulocytes [#/volume] in Blood
157
789
2.09
15.53
2.1
3.0
e9/l
76.0
73.2
0.39
116
588
(3026361) Erythrocytes [#/volume] in Blood
1762
16869
8.18
15.50
30.7
16.8
e12/l
4.5
4.6
16.44
1750
16511
(40761511) CBC panel - Blood by Automated count
1681
15677
2.39
15.48
16.0
10.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
290
1785
1.75
15.43
1.7
1.7
nmol/l
1087.7
1160.0
0.78
230
1402
(3010813) Leukocytes [#/volume] in Blood
1762
16878
8.09
15.29
30.7
16.8
e9/l
6.9
6.7
5.28
1747
16513
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
849
6755
1.49
15.01
5.0
6.3
umol/l
10.2
11.3
1.55
804
6437
(3009871) Measles virus Ab [Titer] in Serum
32
66
4.92
14.76
1.8
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
31
66
4.76
13.79
3.2
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
200
1138
1.85
13.77
4.5
3.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
126
614
2.13
13.50
1.2
1.2
u/ml
2.1
1.3
0.15
16
52
(3014051) Protein [Presence] in Urine by Test strip
67
245
2.80
13.43
2.0
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
601
4542
1.49
13.25
1.9
1.8
pmol/l
92.7
97.0
1.75
370
2520
(3023368) Bacteria identified in Blood by Culture
436
3099
1.54
12.80
4.3
4.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
38
105
3.68
12.07
2.7
3.1
%
52.6
54.7
0.23
24
77
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
93
449
2.13
10.24
1.3
2.0
g/l
1.5
1.5
0.09
71
388
(3026782) Osmolality of Urine
335
2349
1.53
10.22
2.7
2.6
mosm/kgh2o
572.2
559.4
0.48
298
2016
(3019550) Sodium [Moles/volume] in Serum or Plasma
1571
14622
1.65
10.18
13.6
12.5
mmol/l
139.5
139.7
1.73
1544
14289
(3021960) Folate [Moles/volume] in Serum or Plasma
347
2454
1.51
10.17
1.5
1.5
nmol/l
20.2
20.4
0.04
306
2165
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
146
829
1.83
10.09
1.8
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
138
771
1.86
10.05
3.4
2.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
267
1793
1.58
9.87
1.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
281
1923
1.55
9.54
2.7
2.7
e6/l
2.4
2.1
0.16
158
1005
(3023103) Potassium [Moles/volume] in Serum or Plasma
1572
14681
1.62
9.47
13.7
12.6
mmol/l
3.9
4.0
4.96
1539
14319
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
623
4972
1.39
9.44
3.3
3.4
u/l
33.5
35.7
0.26
598
4746
(3026493) Urate [Moles/volume] in Serum or Plasma
472
3598
1.42
9.31
2.2
2.4
umol/l
3236.8
4622.8
0.44
426
3236
(3008757) Leukocyte morphology finding [Identifier] in Blood
37
122
3.08
8.99
2.6
3.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
146
865
1.75
8.76
1.4
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
46
174
2.69
8.74
1.2
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
41
147
2.83
8.62
1.5
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
44
166
2.69
8.42
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
98
522
1.93
8.28
1.3
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
139
835
1.72
7.95
1.7
2.7
g/l
68.9
67.4
1.26
130
787
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
190
1246
1.59
7.73
3.2
4.6
u/l
216.5
239.1
1.98
178
1186
(40768804) Tissue Pathology biopsy report
657
5419
1.34
7.67
1.9
1.9
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
59
269
2.23
7.56
1.7
1.8
g/l
0.6
0.8
0.57
41
210
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
10
13
7.73
7.12
1.6
1.5
mg/l
3.7
3.8
—
10
13
(3042936) Bacteria identified in Isolate by Culture
257
1837
1.47
6.99
2.1
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
321
2400
1.41
6.84
1.2
1.3
u/ml
13.4
8.9
0.46
141
1027
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
465
3698
1.35
6.77
2.2
2.1
u/l
162.9
274.7
1.90
442
3511
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
428
3373
1.35
6.59
1.3
1.3
u/ml
1.1
1.6
0.70
115
958
(3004588) Protein electrophoresis panel - Serum or Plasma
113
680
1.71
6.46
1.7
2.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
102
597
1.75
6.44
1.3
1.3
miu/ml
168.1
220.8
0.74
36
283
(3036670) Protein [Mass/volume] in Synovial fluid
13
26
5.03
6.23
1.2
1.1
g/l
45.3
37.6
—
8
17
(3000494) Fungus identified in Specimen by Culture
233
1674
1.45
6.15
1.4
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
79
435
1.85
6.11
1.6
1.6
g/l
0.2
0.2
0.25
73
411
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
512
4192
1.31
5.98
2.6
2.6
u/l
60.4
56.7
0.39
482
3931
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
422
3365
1.33
5.94
1.7
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
49
230
2.16
5.92
1.8
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
485
3953
1.31
5.83
2.4
3.3
mmol/l
2.3
2.3
1.77
439
3591
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
34
137
2.51
5.79
1.2
1.2
titre
566.0
200.0
—
5
25
(3032080) INR in Blood by Coagulation assay
562
4680
1.29
5.74
7.1
7.2
inr
1.2
1.2
0.24
191
1458
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
330
2552
1.36
5.67
1.2
1.3
iu/ml
23.6
26.6
0.26
101
776
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
56
282
2.02
5.65
1.5
2.6
g/l
0.0
0.0
0.50
50
271
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
80
454
1.80
5.64
1.6
1.6
g/l
1.2
1.2
0.58
74
429
(3022217) INR in Platelet poor plasma by Coagulation assay
182
1268
1.49
5.62
13.1
17.0
inr
1.4
1.2
0.91
31
203
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
21
66
3.21
5.60
2.5
2.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
102
622
1.68
5.59
2.1
2.7
e6/l
0.3
0.2
0.85
95
600
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
36
153
2.38
5.49
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
29
113
2.59
5.31
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
29
113
2.59
5.31
1.0
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
859
7587
1.26
5.29
4.6
4.9
mmol/l
6.4
6.6
2.25
806
7085
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
56
290
1.96
5.24
1.6
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
369
2936
1.32
5.20
2.7
2.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
153
1052
1.50
5.05
2.3
2.3
au/ml
25.2
21.5
—
9
81
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
30
122
2.48
5.05
2.1
2.5
pg
33.1
32.7
0.21
30
122
(3000330) Specific gravity of Urine by Test strip
85
509
1.70
5.01
2.3
2.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
66
3.05
4.95
2.6
2.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
66
3.05
4.95
2.6
2.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
66
3.05
4.95
2.6
2.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
240
1808
1.38
4.83
1.9
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
545
4603
1.27
4.81
3.7
3.0
ng/l
25.3
40.6
2.11
324
2692
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
396
3217
1.30
4.76
1.8
1.8
mg/l
1.0
0.9
0.23
293
2353
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
63
351
1.82
4.76
2.5
3.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
29
120
2.44
4.72
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
342
2727
1.31
4.72
2.8
3.0
ng/l
552.5
956.0
2.31
274
2239
(3036481) Cortisol [Moles/volume] in Serum or Plasma
185
1339
1.43
4.70
2.0
2.1
nmol/l
337.8
367.0
1.39
170
1252
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
58
317
1.86
4.66
1.5
2.6
g/l
0.1
0.9
3.67
51
293
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
25
97
2.60
4.64
1.1
1.2
—
43.2
—
0
5
(3011412) CD3 cells [#/volume] in Blood
32
140
2.31
4.62
1.9
2.6
e9/l
1.0
1.2
0.64
17
80
(3035320) C reactive protein [Mass/volume] in Body fluid
24
92
2.63
4.57
2.2
1.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
356
1.80
4.56
1.5
2.4
g/l
3.1
3.0
0.38
49
285
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1391
13099
1.29
4.52
4.0
4.3
mu/l
1.7
2.0
1.46
1308
12297
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
372
1.78
4.51
1.5
2.3
g/l
4.2
3.8
1.30
47
277
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
372
1.78
4.51
1.5
2.3
g/l
7.3
7.2
0.15
50
294
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
72
426
1.72
4.46
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
72
426
1.72
4.46
1.3
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
24
94
2.57
4.39
1.1
1.2
—
2.4
—
0
5
(42529406) Shigella sp [Presence] in Stool by Culture
72
430
1.70
4.32
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
85
531
1.63
4.31
1.8
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
307
2442
1.31
4.29
1.7
1.6
pmol/l
65926321.7
32113102.9
0.31
270
2130
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
372
1.75
4.24
1.5
2.3
—
—
—
0
0
(3000012) Reticulocyte production index
14
41
3.43
4.18
1.7
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
30
134
2.26
4.16
2.9
2.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
52
286
1.84
4.13
1.6
2.5
g/l
38.6
38.5
0.04
45
260
(3009542) Hematocrit [Volume Fraction] of Blood
1510
14419
1.32
4.11
20.1
12.0
%
40.4
41.3
4.29
1149
11733
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
137
964
1.46
4.07
1.3
1.3
—
40.5
—
0
49
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
8
10
8.03
4.06
1.9
2.0
—
—
—
0
0
(4034850)
73
446
1.66
4.05
12.0
7.8
—
—
—
0
0
(4062490)
34
162
2.12
4.05
1.2
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
63
370
1.73
4.04
1.9
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
247
1923
1.33
4.02
2.5
2.9
mmol/l
2.4
2.4
0.18
217
1705
(36660697) Celiac disease serology panel - Serum
163
1190
1.41
3.97
1.1
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
48
261
1.86
3.97
1.6
2.6
g/l
0.0
0.0
0.00
42
250
(3036071) Salmonella sp Ab [Titer] in Serum
18
64
2.83
3.96
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
43
226
1.93
3.93
1.3
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
185
2431
0.73
3.88
1.3
1.3
—
—
—
0
0
(3013512) EKG study
394
3280
1.26
3.82
3.2
3.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1172
10904
1.22
3.80
3.4
3.8
pmol/l
14.8
14.5
2.65
1089
10174
(3028679) Herpes simplex virus Ab [Presence] in Serum
21
83
2.55
3.80
1.1
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
21
83
2.55
3.80
2.1
2.3
u/field
0.7
2.4
1.58
12
47
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
14
44
3.20
3.78
1.6
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
307
2485
1.28
3.75
2.0
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
15
50
3.02
3.69
3.1
2.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
40
3.27
3.62
3.5
4.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
60
361
1.69
3.56
1.7
3.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
62
377
1.67
3.54
2.4
2.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
42
228
1.86
3.52
1.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
32
158
2.04
3.51
1.8
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
32
158
2.04
3.51
1.8
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
129
925
1.43
3.50
3.2
3.9
mmol/l
1.2
1.2
0.73
120
797
(3005988) Vibrio sp identified in Specimen by Organism specific culture
32
159
2.03
3.46
1.8
1.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
32
159
2.03
3.46
1.2
1.3
g/l
0.4
0.4
0.69
19
112
(3027135) IgG subclass 1 [Mass/volume] in Serum
32
159
2.03
3.46
1.2
1.3
g/l
7.1
6.6
0.44
19
114
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
157
1170
1.38
3.41
2.5
2.3
g/l
0.2
0.2
0.58
147
1104
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
59
358
1.67
3.41
1.3
1.4
—
5.9
—
0
8
(3028192) IgG subclass 2 [Mass/volume] in Serum
32
160
2.02
3.40
1.2
1.3
g/l
3.7
3.0
0.85
19
113
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
73
469
1.58
3.36
2.6
2.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
16
59
2.73
3.32
1.1
1.1
u/l
12.9
13.2
0.04
16
51
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
275
2232
1.27
3.28
1.9
2.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
202
1575
1.32
3.26
3.0
2.9
umol/l
10.4
7.7
0.43
178
1374
(3003458) Phosphate [Moles/volume] in Serum or Plasma
199
1549
1.32
3.26
4.2
6.9
mmol/l
1.0
1.0
0.11
185
1468
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
32
163
1.98
3.25
1.8
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
51
302
1.71
3.23
1.2
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
97
2.28
3.20
1.5
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
202
1581
1.31
3.18
1.7
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
56
342
1.66
3.18
1.6
2.4
g/l
10.9
10.3
0.57
51
298
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
16
61
2.64
3.13
1.1
1.1
u/l
83.3
87.8
0.09
16
53
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
16
61
2.64
3.13
1.4
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
577
6487
0.84
3.10
2.3
2.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
50
2.81
3.09
3.3
2.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
50
2.81
3.09
3.3
2.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
59
369
1.62
3.06
1.2
1.2
u/ml
4.1
10.1
—
7
62
(3044640) Blood type and Crossmatch panel - Blood
468
4055
1.21
3.05
2.5
2.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
31
160
1.95
3.05
1.8
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
18
74
2.45
3.05
1.0
1.1
miu/ml
1750.7
1578.1
0.29
18
74
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1220
11496
1.20
3.05
3.4
3.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
49
293
1.69
3.02
1.3
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
30
154
1.96
3.00
1.4
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
58
364
1.61
2.98
1.2
1.2
u/ml
1.8
2.5
—
5
38
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
364
3083
1.23
2.97
2.4
2.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
141
1058
1.36
2.96
2.6
2.3
ml/min/173m2
74.7
75.1
0.04
46
390
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
694
6245
1.18
2.95
4.0
3.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
42
243
1.75
2.92
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
10
30
3.35
2.90
1.3
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
42
244
1.74
2.88
1.2
1.2
—
36.7
—
0
6
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
81
553
1.49
2.88
2.3
2.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
15
58
2.60
2.87
1.2
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
24
117
2.07
2.77
2.3
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
24
117
2.07
2.77
2.3
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
24
117
2.07
2.77
2.3
1.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
75
0.00
2.75
0.0
1.7
—
127.1
—
0
70
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
47
286
1.66
2.74
1.2
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
14
54
2.61
2.70
2.1
2.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
105
763
1.40
2.70
2.3
2.7
ng/l
98.9
141.6
1.20
94
671
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
161
2045
0.77
2.67
1.7
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
94
674
1.42
2.62
1.9
2.1
u/l
38.6
40.0
0.38
89
621
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
64
426
1.52
2.59
2.2
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
30
163
1.85
2.58
1.9
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
22
107
2.07
2.57
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
22
107
2.07
2.57
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
22
107
2.07
2.57
1.3
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
46
285
1.63
2.53
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
156
1223
1.30
2.47
1.5
1.8
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
22
109
2.03
2.46
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
22
109
2.03
2.46
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
22
109
2.03
2.46
1.3
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
40
2.76
2.37
1.5
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
8
6.26
2.37
1.0
6.1
—
—
—
0
0
(3001729) Color of Synovial fluid
5
8
6.26
2.37
3.2
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
158
1249
1.29
2.36
1.6
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
81
1115
0.71
2.33
1.5
1.6
—
—
—
0
0
(3019225) pH of Specimen
139
1085
1.31
2.29
3.2
4.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
17
79
2.16
2.25
1.5
1.4
u/l
7.4
4.0
—
10
33
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
47
305
1.56
2.18
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
82
596
1.39
2.16
1.6
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
294
0.47
2.16
1.1
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
109
830
1.33
2.15
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
102
1.97
2.10
1.9
2.0
%
20.2
13.3
—
6
48
(3005011) Chlamydia sp Ab [Titer] in Serum
7
20
3.51
2.05
1.7
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
22
391
0.56
2.03
1.4
2.0
iu/l
7.5
4.8
—
5
152
(3037121) Protein [Mass/volume] in Urine
63
442
1.44
2.03
2.1
3.7
g/l
0.2
0.4
1.22
29
210
(21494815) CD4 cells/100 lymphocytes in Specimen
25
142
1.77
1.93
2.2
2.5
%
43.4
43.5
—
5
19
(40768441) Liver Pathology biopsy report
20
106
1.90
1.91
1.1
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
20
106
1.90
1.91
1.3
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
32
196
1.64
1.90
1.2
1.7
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
50
0.00
1.88
0.0
1.4
—
93.9
—
0
27
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
52
0.00
1.88
0.0
1.1
—
92.4
—
0
29
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
22
3.19
1.88
1.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
12
52
2.32
1.87
2.4
3.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
107
1.88
1.86
1.1
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
220
1861
1.21
1.84
1.8
2.3
s
30.2
29.7
0.62
213
1812
(3033658) Prothrombin time (PT) actual/Normal
385
3417
1.16
1.84
4.2
4.0
%
94.3
94.0
0.07
374
3335
(3044889) 12 lead EKG panel
1020
9659
1.13
1.83
3.3
3.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
24
2.92
1.72
1.1
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
31
194
1.61
1.72
1.3
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
103
1.85
1.72
1.1
2.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
13
3.85
1.71
1.2
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
90
696
1.31
1.65
2.5
3.0
mmol/l
1.9
1.5
0.59
65
516
(40760888) Immunoglobulin light chains.free panel - Serum
34
221
1.55
1.63
2.1
3.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
113
1397
0.80
1.57
1.3
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
262
2287
1.17
1.56
4.0
3.3
ng/l
652.0
575.7
0.06
170
1527
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
173
1456
1.21
1.55
6.0
5.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
106
846
1.27
1.55
1.3
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
130
1063
1.24
1.54
7.6
8.1
mmol/l
1.3
1.4
0.19
123
1028
(3051101) Glucose [Moles/volume] in Cord blood
5
15
3.34
1.52
4.2
5.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
259
2264
1.17
1.51
1.5
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
57
418
1.38
1.50
1.9
2.3
mg/l
9.2
10.3
0.49
51
392
(1002224) Polysomnography panel
116
940
1.25
1.50
1.1
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
102
814
1.27
1.50
2.9
4.2
ng/l
69.2
82.6
0.92
96
732
(3022313) Gas panel - Capillary blood
70
531
1.33
1.49
2.8
3.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
37
2.44
1.48
2.0
2.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
37
2.44
1.48
1.1
2.1
—
—
—
0
0
(3009343) pH of Capillary blood
91
719
1.28
1.45
2.7
3.1
ph
7.4
7.4
—
10
87
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
11
52
2.12
1.44
1.7
1.6
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
22
2.73
1.43
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
66
1.98
1.43
1.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
9
39
2.31
1.43
5.6
2.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
246
1.47
1.40
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
46
2.18
1.40
1.6
1.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
19
111
1.72
1.39
1.0
1.1
u/l
1.7
1.1
—
6
57
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
89
706
1.27
1.39
1.5
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
21
127
1.66
1.36
2.4
2.0
mg/l
34.5
22.9
—
6
39
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
91
728
1.26
1.33
2.7
3.1
kpa
5.1
5.2
0.24
85
683
(3029396) Erythrocyte agglutination [Presence] in Blood
0
40
0.00
1.32
0.0
3.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
56
738
0.75
1.32
2.3
1.8
mg/l
7.0
3.7
0.53
44
509
(3048879) Bone marrow aspiration report
6
24
2.50
1.30
2.3
3.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
34
2.36
1.29
1.9
1.1
%
91.6
97.9
—
8
34
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
34
2.36
1.29
1.8
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
36
251
1.44
1.29
1.1
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
136
1144
1.20
1.27
8.6
10.1
%
96.0
96.2
0.13
131
1103
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1422
13868
1.13
1.25
3.8
3.8
mmol/l
5.7
5.9
4.56
1347
12987
(3020891) Body temperature
59
454
1.31
1.19
4.4
5.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
32
452
0.70
1.18
1.7
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
245
2177
1.15
1.18
1.4
1.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
10
50
2.01
1.16
1.1
2.3
—
55782.9
—
0
8
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
45
334
1.36
1.16
1.6
1.5
e6/l
12946.7
1915.1
0.41
40
271
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
45
334
1.36
1.16
1.5
1.4
e6/l
31.6
13.0
0.39
38
262
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
20
2.50
1.15
1.0
2.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
20
2.50
1.15
1.6
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
175
1.49
1.13
1.3
1.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
30
2.34
1.12
12.3
12.5
—
—
—
0
0
(3017704) Immunofixation for Urine
11
58
1.90
1.12
1.2
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
170
1477
1.17
1.12
3.6
3.9
%
31.0
30.3
0.45
133
1087
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
14
81
1.73
1.09
1.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
24
161
1.50
1.07
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
23
153
1.51
1.06
1.7
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
151
1738
0.86
1.05
1.8
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
110
927
1.20
1.04
3.2
2.2
ug/l
7.3
8.0
0.12
98
840
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
149
0.53
1.03
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
35
255
1.38
1.03
2.2
3.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
33
238
1.39
1.03
1.9
2.2
g/l
138.2
135.0
0.28
23
171
(4211845)
9
47
1.92
1.02
5.6
2.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
5
107
0.47
1.01
1.0
1.0
—
0.4
—
0
24
(3000492) Spirometry study
193
1708
1.15
1.01
1.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1347
13146
1.10
1.01
4.6
4.8
mmol/mol
37.2
38.9
11.37
1290
12462
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
44
573
0.76
1.00
1.6
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
119
1015
1.18
1.00
3.1
4.6
ug/l
209.8
20.0
0.68
90
808
(3027801) Oxygen [Partial pressure] in Arterial blood
148
1287
1.16
0.98
8.1
9.4
kpa
13.2
12.8
0.39
139
1239
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
148
1287
1.16
0.98
8.1
9.4
kpa
5.2
5.1
0.32
139
1237
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
29
0.00
0.97
0.0
1.3
—
1.7
—
0
29
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
10
54
1.86
0.96
1.7
1.2
—
64.4
—
0
9
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
41
311
1.33
0.95
2.0
1.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
32
0.00
0.95
0.0
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
20
133
1.51
0.94
2.7
2.7
e6/l
956.1
711.2
0.50
12
50
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
16
101
1.59
0.93
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
184
0.60
0.92
1.5
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
55
1.82
0.92
1.0
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
146
1280
1.15
0.89
8.2
9.5
mmol/l
1.1
1.0
0.23
115
1012
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
147
1291
1.15
0.88
3.3
2.6
u/l
37.7
75.3
0.53
128
1136
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
486
4564
1.09
0.88
3.8
3.7
ug/l
1.9
1.8
0.18
440
4198
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
30
220
1.37
0.87
2.3
2.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
72
595
1.22
0.86
10.6
12.0
mmol/l
24.9
24.3
0.90
65
572
(3034860) Kappa light chains.free [Mass/volume] in Serum
38
290
1.32
0.86
2.1
3.9
mg/l
38.0
66.6
0.66
28
226
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
38
290
1.32
0.86
2.1
3.9
mg/l
28.3
32.8
0.43
28
225
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
196
1.38
0.84
1.3
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
137
0.58
0.83
1.3
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
68
815
0.83
0.80
1.6
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
140
1237
1.14
0.79
3.2
3.0
—
—
—
0
0
(4146454)
7
122
0.57
0.78
2.7
2.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
28
208
1.35
0.77
3.3
4.3
u/ml
788.6
232.8
0.38
23
198
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
38
483
0.78
0.77
1.6
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
54
440
1.23
0.76
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
57
468
1.23
0.75
1.4
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
26
192
1.36
0.75
1.3
2.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
23
167
1.38
0.73
1.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
55
1.64
0.73
1.2
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
55
1.64
0.73
1.2
2.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
224
2047
1.11
0.73
3.2
3.9
mmol/l
0.8
0.8
0.66
208
1945
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
56
1.61
0.72
1.2
1.4
—
—
—
0
0
(4024509)
12
76
1.58
0.71
1.5
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
23
168
1.37
0.71
1.3
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
21
287
0.73
0.71
1.5
1.5
nmol/l
0.2
0.3
2.29
14
229
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
229
0.70
0.71
1.3
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
160
1.38
0.70
2.3
2.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
27
1.85
0.68
1.0
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
43
1.63
0.67
1.1
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
30
384
0.78
0.66
1.7
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
26
197
1.32
0.66
2.0
2.3
umol/l
6.2
6.1
0.02
16
142
(3048929) Epstein Barr virus Ab [Presence] in Serum
70
597
1.18
0.65
1.2
1.2
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
11
70
1.57
0.65
1.6
1.1
u/l
264.4
519.7
0.63
11
61
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
36
449
0.80
0.65
1.5
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
45
368
1.23
0.64
1.4
1.4
ug/g
279.7
308.3
0.33
25
202
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
22
163
1.35
0.64
1.2
1.3
nmol/l
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
36
448
0.80
0.64
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
36
448
0.80
0.64
1.5
1.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
8
127
0.63
0.64
1.6
1.5
mmol/l
2.9
1.9
—
8
120
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
36
447
0.80
0.63
1.5
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
28
358
0.78
0.62
1.6
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
49
406
1.21
0.62
4.2
3.9
u/ml
13421.9
3417.3
0.45
43
348
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
101
0.59
0.62
2.5
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
101
0.59
0.62
5.0
5.8
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
0.0
—
0
11
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
3.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
0.0
—
0
13
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
29
228
1.28
0.58
1.8
1.7
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
2.2
—
0.5
—
0
17
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
31
387
0.80
0.58
1.3
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
112
0.62
0.58
1.9
3.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
30
375
0.80
0.57
1.5
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
229
1.27
0.57
1.3
1.7
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
36
1.67
0.56
1.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
115
1.39
0.56
1.9
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
38
311
1.23
0.56
1.4
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
120
1080
1.12
0.55
5.0
9.2
mmol/l
8.0
8.4
0.30
113
1036
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1083
11066
0.95
0.55
3.2
3.1
u/l
49.9
46.9
0.53
1033
10572
(3005033) Fetal Nuchal fold Thickness US
30
373
0.80
0.55
1.5
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1371
13504
1.07
0.54
25.0
14.2
g/l
331.9
334.2
17.65
1366
13413
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
125
0.64
0.54
1.0
1.2
—
—
—
0
0
(44790049)
11
159
0.69
0.54
1.3
1.7
—
—
—
0
0
(44806118)
11
159
0.69
0.54
1.3
1.7
—
—
—
0
0
(44790048)
11
159
0.69
0.54
1.3
1.7
—
—
—
0
0
(44790047)
11
159
0.69
0.54
1.3
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
9
61
1.48
0.53
1.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
37
304
1.22
0.53
2.2
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
332
1.21
0.52
3.5
3.1
u/ml
0.3
0.3
0.04
24
173
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
100
0.60
0.51
2.5
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
59
510
1.16
0.50
1.5
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
78
689
1.14
0.50
1.8
2.3
u/l
2510.4
4632.5
0.61
29
263
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.49
1.5
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.49
1.5
1.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
67
1.50
0.49
1.1
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
14
101
1.39
0.49
2.2
3.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
21
268
0.78
0.49
1.1
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
118
1071
1.11
0.49
1.1
1.2
iu/ml
74.6
142.4
1.36
41
427
(40768800) Prostate Pathology biopsy report
27
217
1.25
0.48
1.3
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
128
1.33
0.47
1.3
1.2
u/ml
0.1
0.3
—
6
55
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
47
1.49
0.47
1.0
2.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
109
987
1.11
0.47
9.4
9.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
386
3683
1.06
0.47
1.6
1.6
mmol/l
1.4
1.5
1.06
335
3184
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
173
1.28
0.46
1.3
1.6
—
—
—
0
0
(4027681)
16
120
1.34
0.46
1.1
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
7
49
1.43
0.46
1.3
2.0
—
—
—
0
0
(4281824)
8
118
0.68
0.45
1.5
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
242
2570
0.93
0.45
1.9
1.9
%
1.5
1.4
0.82
220
2330
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
77
1.43
0.45
1.4
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
50
1.40
0.45
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
50
1.40
0.45
1.3
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
42
357
1.18
0.45
1.3
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
105
953
1.11
0.44
2.3
2.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
40
469
0.85
0.44
1.7
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
18
139
1.30
0.43
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
148
1.29
0.43
3.0
1.9
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
140
0.71
0.43
1.1
1.6
g/l
0.8
1.0
—
10
140
(3012501) Base excess in Blood by calculation
31
257
1.21
0.43
3.3
3.9
mmol/l
2.9
2.4
0.32
22
168
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
31
1.61
0.43
1.0
1.0
mg/g
5.1
9.8
—
5
31
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
56
1.43
0.42
1.3
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
87
1.38
0.42
1.4
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
33
1.52
0.41
3.8
7.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
15.9
—
0
15
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
33
277
1.19
0.41
1.1
1.0
u/ml
2.9
2.4
—
6
143
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
10.3
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
17
0.00
0.40
0.0
1.4
—
10.1
—
0
8
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
60
1.33
0.40
1.9
1.4
ug/l
9.0
8.4
—
8
60
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
60
1.33
0.40
1.5
3.0
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
2.0
—
0
10
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
18
0.00
0.40
0.0
3.3
—
—
—
0
0
(3010421) pH of Blood
36
306
1.18
0.39
3.1
3.8
ph
7.4
7.4
0.32
30
252
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
102
0.69
0.39
1.3
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
173
1619
1.08
0.39
2.2
2.3
nmol/l
14.2
13.8
0.28
154
1489
(44806420)
0
19
0.00
0.39
0.0
2.5
—
—
—
0
0
(4306422)
33
279
1.19
0.39
1.2
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
283
2696
1.06
0.38
2.5
2.5
ug/l
0.7
0.7
0.30
183
1477
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
12
89
1.35
0.38
2.2
1.6
—
1357281.3
—
0
8
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
70
629
1.12
0.37
11.4
12.9
—
—
—
0
0
(4198724)
8
112
0.71
0.37
1.8
3.7
—
—
—
0
0
(44813793)
14
107
1.31
0.37
1.1
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
22
267
0.82
0.36
5.3
2.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
41
470
0.87
0.36
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
107
987
1.09
0.35
2.1
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
14
108
1.30
0.35
1.7
2.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
125
0.72
0.35
1.7
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
30
255
1.18
0.34
1.3
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
218
1.20
0.34
1.4
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
78
710
1.10
0.34
5.4
6.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
98
904
1.09
0.33
2.3
2.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
83
760
1.10
0.33
2.4
2.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
407
3933
1.05
0.32
3.1
3.4
mmol/l
8.4
8.5
0.13
363
3400
(3008152) Bicarbonate [Moles/volume] in Arterial blood
76
694
1.10
0.32
7.5
9.1
mmol/l
25.3
24.6
1.37
68
647
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
84
772
1.09
0.31
1.6
1.9
nmol/l
34.3
36.6
0.61
84
754
(3013139) Helicobacter pylori Ag [Presence] in Stool
100
927
1.08
0.31
1.2
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
41
362
1.14
0.30
1.3
1.5
—
17.1
—
0
7
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
80
735
1.09
0.30
1.5
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
105
977
1.08
0.30
2.3
2.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
34
388
0.87
0.29
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
48
535
0.89
0.29
1.4
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
106
0.75
0.29
1.1
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
34
387
0.88
0.29
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
110
0.73
0.29
1.8
2.1
%
10.3
11.5
—
8
110
(3000764) Benzodiazepines [Presence] in Urine
104
970
1.08
0.28
2.3
2.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
121
1.24
0.28
1.7
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
105
980
1.08
0.28
2.3
2.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
10
76
1.32
0.28
1.0
1.1
iu/ml
100.1
202.5
—
10
76
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
76
1.32
0.28
1.5
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
94
1.28
0.28
1.3
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
85
1.30
0.28
6.3
7.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
194
0.82
0.27
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
119
0.76
0.27
2.0
2.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
122
1.23
0.27
1.7
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
172
1639
1.05
0.26
1.3
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
19
224
0.85
0.25
2.5
2.7
mmol/l
1.3
1.6
0.71
19
218
(3016018) Differential panel - Cerebral spinal fluid
19
160
1.19
0.25
1.7
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
25
217
1.15
0.24
2.4
3.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
77
1.17
0.24
5.2
2.5
ug/l
26.2
438.9
—
9
67
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
133
1.20
0.24
3.4
2.0
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
6
81
0.74
0.24
30.3
27.3
ug/l
105.0
124.7
—
6
65
(3051651) Icteric interference index of Serum or Plasma
6
83
0.72
0.24
1.3
3.6
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
23
265
0.87
0.24
1.0
1.0
u/ml
0.0
0.4
—
6
59
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
133
1262
1.06
0.23
2.2
2.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
26
228
1.14
0.22
1.9
2.3
%
18.0
17.0
0.43
14
115
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
92
0.76
0.22
1.1
2.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
94
0.74
0.22
1.0
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
24
210
1.14
0.21
1.1
1.5
pmol/l
130.5
203.4
—
6
69
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
42
1.19
0.21
1.0
2.1
ug/l
54.3
48.3
—
5
42
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
11
0.00
0.21
0.0
1.0
—
21.0
—
0
6
(3025549) Creatine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.0
—
1.5
—
0
5
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
83.3
—
0
10
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
10
0.00
0.21
0.0
3.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
277
1.12
0.21
1.4
1.2
u/ml
4.1
5.2
0.14
12
88
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
12
0.00
0.21
0.0
5.0
—
485.3
—
0
12
(3022475) Manganese [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
22
251
0.87
0.21
2.7
3.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
89
1.24
0.21
1.0
1.1
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
10.6
—
0
5
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.3
—
0
7
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
37
335
1.11
0.20
1.3
1.5
u/ml
92.3
116.1
0.81
11
63
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1418
14271
0.97
0.20
3.7
3.6
mmol/l
1.3
1.4
1.40
1352
13498
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
134
0.82
0.20
1.8
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
27
303
0.89
0.20
1.0
1.0
u/ml
2.5
3.4
0.30
12
114
(3023430) Cat dander IgE Ab [Units/volume] in Serum
25
282
0.88
0.20
1.0
1.1
u/ml
4.6
4.6
0.01
13
110
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
6.8
—
0
14
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
48
1.25
0.20
1.2
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
111
0.81
0.20
1.6
2.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
114
0.79
0.20
2.8
4.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
42
384
1.10
0.20
1.2
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
79
744
1.06
0.19
1.4
1.6
mu/l
260.2
280.4
0.16
70
687
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
25
222
1.13
0.19
2.2
2.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
53
1.13
0.18
1.0
1.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
20
175
1.14
0.18
1.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
59
1.19
0.18
1.1
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
25
279
0.89
0.18
1.5
1.5
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
7
60
1.17
0.17
1.1
1.1
—
411.3
—
0
15
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
45
416
1.08
0.17
1.6
2.3
ug/l
255.4
285.0
0.07
37
391
(3015183) Erythrocyte sedimentation rate
13
110
1.18
0.17
1.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1506
14989
1.03
0.17
4.2
4.2
mmol/l
2.9
2.9
1.74
1437
14178
(3045716) Anion gap in Serum or Plasma
5
66
0.76
0.17
1.4
1.8
mmol/l
11.2
9.3
—
5
53
(3000093) Morphology [Interpretation] in Blood Narrative
12
101
1.19
0.16
1.3
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
24
267
0.90
0.16
1.2
1.1
—
9.4
—
0
25
(3003694) ABO and Rh group [Type] in Blood
429
4210
1.03
0.16
1.5
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
92
1.20
0.16
1.5
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
24
216
1.11
0.15
3.1
3.5
u/ml
3.6
60.0
0.50
24
202
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
54
575
0.94
0.15
4.4
3.9
mmol/l
24.2
24.3
0.08
46
522
(3042111) Morphology [Interpretation] in Bone marrow Narrative
20
178
1.13
0.15
2.2
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
43
400
1.08
0.15
1.5
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
140
1.14
0.15
1.3
2.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
81
1.11
0.15
3.8
3.4
u/ml
894.0
819.4
—
9
81
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1491
14845
1.03
0.15
4.0
4.0
mmol/l
4.7
4.8
1.38
1430
14126
(3006653) Thiamine [Moles/volume] in Blood
9
82
1.10
0.15
1.4
1.4
nmol/l
134.0
142.8
—
9
82
(3025130) Human papilloma virus identified in Specimen
23
208
1.11
0.14
2.2
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
8
96
0.83
0.13
1.0
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
8
96
0.83
0.13
1.1
1.4
g/l
35.8
33.2
—
8
83
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
98
0.82
0.13
2.3
1.7
—
—
—
0
0
(4035726)
111
1069
1.04
0.13
1.3
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
113
1.15
0.13
3.4
2.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
12
138
0.87
0.13
1.1
1.4
nmol/l
1.5
1.4
0.17
12
128
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
31
287
1.08
0.12
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1484
14786
1.02
0.11
3.9
3.9
mmol/l
1.4
1.4
1.62
1417
14017
(3047181) Lactate [Moles/volume] in Blood
35
374
0.93
0.11
7.7
8.6
mmol/l
1.2
1.2
0.28
29
325
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
95
916
1.04
0.11
2.2
3.4
pmol/l
4.7
4.6
0.11
86
826
(3012516) Albumin [Mass/volume] in Urine
349
3435
1.02
0.11
3.0
3.4
mg/l
628.2
409.2
0.28
217
2281
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
28
301
0.93
0.11
2.1
2.4
ug/min
73.8
136.2
1.05
17
183
(4133840)
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
58
556
1.04
0.09
1.6
2.1
s
20.5
21.1
0.56
47
490
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
233
1.07
0.09
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
233
1.07
0.09
1.5
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
63
0.79
0.08
1.2
1.3
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
7
64
1.09
0.08
1.1
2.3
—
17.0
—
0
8
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
65
1.08
0.08
1.1
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
66
1.06
0.08
2.4
2.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
75
0.80
0.07
1.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
75
0.80
0.07
1.2
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
75
0.80
0.07
1.0
1.5
—
—
—
0
0
(4268621)
20
186
1.08
0.07
2.2
2.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
11
122
0.90
0.07
1.8
2.3
mmol/l
4.1
4.0
0.53
11
122
(3035285) Chloride [Moles/volume] in Venous blood
11
122
0.90
0.07
1.8
2.3
mmol/l
106.0
105.7
0.08
11
122
(3002032) Base excess in Venous blood by calculation
103
1053
0.98
0.06
3.7
3.8
mmol/l
1.8
2.0
0.27
85
846
(3028707) Methadone [Presence] in Urine by Screen method
42
404
1.04
0.06
3.6
3.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
213
0.94
0.06
1.3
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
98
959
1.02
0.06
1.4
1.3
iu/l
23.6
25.8
0.28
87
817
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
182
0.93
0.05
1.3
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
33
344
0.96
0.05
1.0
1.1
u/ml
0.6
2.3
—
7
85
(3015235) Bicarbonate [Moles/volume] in Capillary blood
29
277
1.05
0.05
2.0
2.6
mmol/l
24.7
24.7
0.01
23
250
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
43
416
1.03
0.05
2.8
2.9
mg/l
1.3
1.4
0.67
43
390
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
13
120
1.08
0.05
1.1
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
22
209
1.05
0.04
1.1
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
131
1.07
0.03
2.1
1.9
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
38
391
0.97
0.03
1.0
1.1
u/ml
3.0
1.9
0.16
16
154
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
36
370
0.97
0.03
1.2
1.2
u/ml
330.4
264.0
0.53
22
231
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
112
1.07
0.03
1.2
3.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
122
1.07
0.02
2.7
2.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
364
3623
1.01
0.02
3.3
3.3
%
21.7
21.0
0.39
164
1347
(3003888) Timothy IgE Ab [Units/volume] in Serum
37
361
1.03
0.02
1.0
1.1
u/ml
2.2
5.6
2.18
19
184
(3020682) Albumin/Creatinine [Ratio] in Urine
361
3595
1.01
0.02
3.8
4.1
mg/mmol
6.5
9.9
1.63
237
2374
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
20
208
0.96
0.02
1.2
1.1
%
102.7
97.4
0.39
20
198
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
35
342
1.02
0.01
1.6
1.7
—
—
—
0
0
(4094501)
40
392
1.02
0.01
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
186
1850
1.01
0.01
1.7
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
53
523
1.01
0.01
1.4
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
106
0.94
0.01
1.1
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
16
154
1.04
0.00
1.8
1.8
nmol/l
20.0
19.7
0.05
16
145
(3008401) Mugwort IgE Ab [Units/volume] in Serum
35
344
1.02
0.00
1.0
1.1
u/ml
0.5
1.4
1.14
13
135
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
105
1.05
0.00
1.9
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
14
135
1.04
0.00
1.4
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
119
1.01
0.00
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
269
1.00
0.00
3.0
3.1
mg/l
18.0
24.4
0.50
19
165
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
20
196
1.02
0.00
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
65
646
1.01
0.00
3.2
3.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
19
188
1.01
0.00
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
28
278
1.01
0.00
1.3
1.2
u/ml
5.2
4.4
—
10
116
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
137
1.02
0.00
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
16
157
1.02
0.00
1.8
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
62
617
1.01
0.00
1.3
1.4
u/l
7.8
8.3
0.13
55
511
(4010399)
94
937
1.00
0.00
1.5
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
2.1
—
0
6
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
12.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
69
1.01
0.00
1.0
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
138.1
—
0
5
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.4
—
42.1
—
0
9
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3004451) EKG impression Narrative
6
68
0.88
0.00
1.0
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
1.0
—
0
6
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(3012565) Volume of 24 hour Urine
7
73
0.96
0.00
2.0
3.0
ml
1990.0
2086.4
—
7
67
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
7.6
—
0
5
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
8.2
—
0
6
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
60
1.00
0.00
5.7
3.3
—
—
—
0
0
(3024471) HLA-A [Type]
6
65
0.92
0.00
1.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
7
0.00
0.00
0.0
1.1
—
36.4
—
0
7
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
64
0.94
0.00
1.7
1.1
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
59
0.85
0.00
1.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
0.1
—
0
7
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_ANKYLOSPON_STRICT and mortality.

Females

Parameter HR [95% CI] p-value
M13_ANKYLOSPON_STRICT 0.709 [0.53, 0.95] 0.019
Birth year 0.993 [0.98, 1.0] 0.138

During the follow-up period (1.1.1998 — 31.12.2019), 51 out of 2980 females with M13_ANKYLOSPON_STRICT died.

Males

Parameter HR [95% CI] p-value
M13_ANKYLOSPON_STRICT 0.829 [0.71, 0.96] 0.015
Birth year 0.988 [0.98, 1.0] 0.014

During the follow-up period (1.1.1998 — 31.12.2019), 218 out of 4769 males with M13_ANKYLOSPON_STRICT died.

Mortality risk

Mortality risk for people of age

years, who have M13_ANKYLOSPON_STRICT.

N-year risk Females Males
1 0.071% 0.139%
5 0.43% 1.001%
10 1.008% 2.594%
15 1.862% 4.725%
20 3.295% 8.268%

Relationships between endpoints

↥

Index endpoint: M13_ANKYLOSPON_STRICT – Ankylosing spondylitis, strict definition

GWS hits: 12

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data